EULAR evidence-based recommendations for the management of fibromyalgia syndromeSerena Carville, Ernest Choy, K. G. Henriksson et al.|Annals of the Rheumatic Diseases|2007Cited by 751
EULAR definition of difficult-to-treat rheumatoid arthritisGyörgy Nagy, Jacob M. van Laar, Nadia M T Roodenrijs et al.|Annals of the Rheumatic Diseases|2020Cited by 538
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trialFrances Humby, Raquel Celis, Patrick Durez et al.|The Lancet|2021Cited by 315
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritisGyörgy Nagy, Jacob M. van Laar, Nadia M T Roodenrijs et al.|Annals of the Rheumatic Diseases|2021Cited by 273
Hypothetical model ignores many important pathophysiologic mechanisms in fibromyalgiaDaniel J. Clauw, Gary J. Macfarlane, Ernest Choy et al.|Nature Reviews Rheumatology|2023Cited by 10